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The effect of conformational changes of the a,-proteinase inhibitor (a,PI) on a,PI--cholesterol complex (1:2 mol/mol) formation in vitro was studied 
wtth electrophoretic and gel chromatographic methods. Native a,PI was modified by adding free thiol agents such as glutathione. cysteine HCl, 
or oL-homocysteine, by heating. or by cleavage with pancreatic elastase or trypsin. Conformational changes of the a,PI molecule Induced by these 
procedures were all accompamed by a loss of its ability to bind cholesterol in vitro under standard experimental conditions. The data suggest 
a,PIIcholesterol binding to be affected by both direct and indirect modifications of the ol,PI-reactive center, that is situated on a mobile peptide 
loop. 
a,-Proteinase inhibitor; Cholesterol; Complex formatton 
1. INTRODUCTION 
Complex formation in vitro between human a,-pro- 
teinase inhibitor (a,PI) and cholesterol was demon- 
strated in a recent study [l]. It was shown that this 
interaction results in an abnormal a,Pl immunoprecipi- 
tation pattern, diminished antiproteinase activity, and 
a gel filtration peak at 67 kDa (as compared to 52 kDa 
for native a,PI). Like other serine antiproteinases (ser- 
pins), a,PI has a highly ordered structure and its prop- 
erties are critically dependent on the conformationally 
constrained active site loop [5]. To function as inhibitors 
the serpins have a native, stressed (S) conformation that 
renders them vulnerable to proteolytic cleavage, the 
cleavage being accompanied by an irreversible transi- 
tion to a stable relaxed (R) form [3]. Modifications in 
the loop sequence due to species differences, genetic 
variation or physical and chemical alterations result in 
changes of the predominant function of a,PI as an in- 
hibitory serpin [4]. The single cysteine at position 232 
in the a,PI molecule has been shown to participate in 
mixed disulfide formation with cysteine, glutathione 
and plasma proteins with free thiols [5]. Conforma- 
tional changes induced by modification of Cys-232 di- 
rectly affect the conformationally constrained active site 
loop and changes the affinity of a,PI for neutrophil 
elastase [5]. Our goal in this study was to investigate the 
effects on the conserved a,PT tertiary structure induced 
by temperature, disulfide bond formation, cleavage 
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with target enzymes on the a,PIcholesterol complex 
formation in vitro. 
2. MATERIALS AND METHODS 
Electrophoretically pure a,PI was isolated from human plasma in 
our laboratory as previously described [l]. A standard aqueous solu- 
tion of cholesterol was obtained from Boehringer Mannheim. Ger- 
many, glutathione (GSH), oL-homocysteine and cysteine-HCl were 
from Sigma. St. Louis. MO, porcine pancreas elastase type III from 
Sigma, and lyophihzed bovine trypsm (266 U/mg) from Worthington 
Biochemtcal Corporation, Freehold, NJ. Monospectfic rabbit antise- 
rum against human a,PI was purchased from DAKO. Denmark and 
agarose. Sephadex G-75 superfine and the gel filtration cahbratton kit, 
from Pharmacia, Uppsala. Sweden. All other chemicals were of rea- 
gent grade. 
In the experiments we used stock solutions ofa,PI (1.78 mg/ml, 0 34 
PM/ml) and cholesterol (2 mg/ml) in 0.015 M Tris buffer, pH 7.4, 
containmg 0.15 M NaCl. Solutions of glutathione. cysteme-HCI and 
DL-homocysteine (300 pmol/ml) were prepared m 1 M glycme. 0.01 M 
Na]-EDTA buffer. pH 7.4. 
Disulfide forms of a,PI were prepared by mixing a,PI (0.34pM/ml) 
with glutathione, cysteine or oL-homocysteme (300 PmoYml) at vol- 
ume ratios 5 or 10 of a,PI to 1 free thiol reagent in Tris buffer, pH 
7.4. Samples were kept overnight at +4”C. Temperature modified a,PI 
was prepared by keepmg a,PI at 56°C for 5 min resulting in a 50% 
reduction of anttelastase activity Elastase mhibttory activity was ana- 
lyzed as described by Gaillard and coworkers [7] 
For elastase-a,PI or trypsin--a,PI complex formation. reaction mrx- 
tures containing protemase and a,PI I 1: 1 1 mollmol) were incubated 
at 37°C m the Tris buffer (15 min for elastase and 1 h for trypsin). 
The complex between native or modified a,PI and cholesterol was 
prepared by mixing a,PI with cholesterol (12 mol/mol) in Tris buffer 
and incubated for 24 h at 37’C Under these standard experimental 
condmons the complex formed had a typical immune precipitate pat- 
tern and a gel filtration peak at 67 kDa [l]. 
Gel filtration, electrophoresis in 1% agarose. and crossed immuno- 
electrophoresis were performed as previously described [l]. Rocket 
tmmunoelectrophorests was performed as described by Laurel1 [8]. 
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Fig. 1. Crossed immunoelectrophoresis of modified forms of a,PI (see text). A, B. C, D: 1, native cc,PI; A, B, C, D: 2. a,PlIcholesterol complex 
showing the retarded double peak; A3, disulfide form of a,PI mixed with cholesterol; A4, disulfide form of a,PI prepared by adding glutathione; 
B3, heated cqPIcholestero1 mixture; B4, a,PI heated at 56°C for 5 min; C3, elastase cleaved a,PIIcholesterol mixture; C4. elastase-a,PIIcholesterol 
mixture; D4, trypsin-a,PI complex Anode (+) to the left. Vertical lines indicate identical mobihties. 
3. RESULTS AND DISCUSSION 
3.1. Effects of disulfide formation 
Complex formation between native or modified a,PI 
and cholesterol (1:2 mol/mol) was visualized with 
crossed immunoelectrophoresis. As shown previously 
KP[l], and as seen in Fig. lA-2, the complex formation 
results in typically double peaked immune precipitate 
with retarded mobility towards the anode. When the 
disulfide form of a,PI prepared by adding glutathione 
was mixed with cholesterol, no effect on the im- 
munoprecipitate pattern (as compared to native PI) 
could be seen (Fig. lA-3). Identical results (not shown) 
were obtained when cysteine-HCl or homocysteine were 
used for disulfide formation. 
Similarly, when samples of the disulfide form of o+PI 
and cholesterol mixtures were subjected to gel filtration 
both native a,PI and the disulfide form mixed with 
cholesterol eluted at 52 kDa, in contrast to native a,PI 
in complex with cholesterol which appeared at a molec- 
ular size of 67 kDa (Fig. 2).C Despite the loss of cholest- 
erol binding activity disulfide formation did not cause 
any reduction in antiproteinase activity. 
3.2. Effects of temperature 
When native a,PI was subjected to heating at 56°C 
for 5 min it lost about 50% of its antielastase activity but 
its ability to bind cholesterol under standard experimen- 
tal conditions was completely abolished (Fig. lB-3). 
The heated protein was also found to elute with a nor- 
mal size, 52 kDa, from the Sephadex column (not 
shown). 
3.3. Effects of proteolytic cleavage 
The cleavage of native a,PI by its target enzyme, 
elastase, or by trypsin. results in the transition from a 
stressed (S) form to a relaxed (R) form of the protein 
[3]. The cleavage products can be visualized by crossed 
immunoelectrophoresis. As can be seen in Fig. lC-4, 
D-4 cleavage resulted in the appearance of an electro- 
phoretically retarded (cqPI-proteinase complex) form 
of a,PI. It is also seen that the transition from an S to 
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Fig. 2. Gel filtration of native a,PI (O-O). native a,PIIcholesterol 
mixture 1 M:2 M (A-A) and disulfide form a,PIIcholesterol (O-O) 
mixture I M:2 M on a Sephadex G-75 superfine column. 
an R form abolishes the ability of a,PI to bind choles- 
terol (Fig. lC-3; D-3). For unknown reasons, a,PI- 
elastase and -trypsin complexes differ from each other 
in their reaction to the addition of cholesterol (C-3, 
C-4). 
These results suggest that the cholesterol binding site 
of a,PI is located on or close to the active site loop of 
the molecule. Modest heating results in some loss of 
biological activity, but has a marked effect on the terti- 
ary structure sufficient to result in a complete loss of 
cholesterol binding capacity under standard experimen- 
tal conditions. Similarly the direct effect of target en- 
zymes on the reactive center abolishes the cholesterol 
binding ability of a,PI. 
On the other hand the induction of conformational 
changes in the cqP1 molecule by disulfide bond forma- 
tion between free thiols and Cys-232, which is protected 
in a crevice [lo], also abolishes the ability of cqP1 to bind 
cholesterol. Tyagi and coworkers [6] have shown disul- 
fide bond formation involving the Cys-232 of a,PI to 
induce conformational changes in the protein’s reactive 
site without causing any decline in antiproteinase activ- 
ity. Our results are in agreement with their findings; we 
detected no loss of cqP1 antielastase activity after disul- 
fide bond formation. The fact that, after disulfide bridge 
formation between Cys-232 and free thiol agents, a,PI 
lost its ability to interact with added cholesterol suggests 
the presence of an additional cholesterol binding site 
which is located in the hydrophobic [I 1] Cys-232 envi- 
ronment of the ol,PI molecule. 
Our results suggest a,PI-cholesterol complex forma- 
tion in vitro to be dependent on a conformationally 
constrained reactive site loop. Complex formation is 
blocked by both direct (heating, proteolytic cleavage) 
and indirect (disulfide formation) processes affecting 
this region. 
Acknowledgements: This work was supported by grants from the 
Ernhold Lundstrom’s and Anna and Edwin Berger’s Foundations. 
REFERENCES 
111 
121 
[31 
[41 
[51 
K51 
t71 
PI 
[91 
FOI 
HII 
Janciauskiene, S. and Eriksson. S. (1993) FEBS Lett. 316. 369- 
272. 
Carrel], R.W. and Evans, D.L.I. (1992) Curr. Opm. Struct. Biol. 
2, 438446. 
Carrell, R.W. and Owen, M.C. (1985) Nature 317. 269-272. 
Padrines, M.. Schneider-Pozzer. M. and Bieth, J.G. (1989) Am. 
Rev. Resp. Dis. 139. 783-790. 
Laurell. C.B. (1974) Immunochemistry 11, 703-709. 
Tyagi, S.C. and Simon, S.R. (1992) Biochemistry 31, 10584 
10590. 
Gaillard. M.C., Ktlrel-Smtth, T.A.. Nagueira, C., Dunn, D., Jen- 
kins, T., Fine, B. and Kallenbach (1992) J Am Rev Resp Dis. 
145, 1311-1315. 
Laurell. C.B. (1972) Stand. J Chn Lab. Invest., suppl. 124. 
21-37. 
Pemberton, P.A , Stein. P.E., Pepys. M.B., Potter, J.M. and Car- 
rel, R.W. (1988) Nature 336. 257-258. 
Loeberman. H., Tokuoka. R.. Deisenhofer, J. and Huber, R. 
(1984) J. Mol. B~ol. 177, 531-556. 
Tyagi. S.C. (1991) J. Biol. Chem. 266. 527995285. 
238 
